A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Gerald Falchook, MD
Sarah Cannon Cancer Institute, HealthOne Denver
Principal Investigator - Udai Banerji, Prof
Institute of Cancer Research, Royal Marsden NHS Foundation Trust
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Western General Hospital - Nhs Lothian
Edinburgh, United Kingdom
Completed - the Royal Marsden Nhs Foundation and Trust
London, United Kingdom
Completed
- Mayo Clinic
Phoenix, Arizona, United States
Recruiting - Uc San Diego Moores Cancer Center
La Jolla, California, United States
Recruiting - Sarah Cannon Research Institute at Healthone
Denver, Colorado, United States
Recruiting - Mayo Clinic
Jacksonville, Florida, United States
Recruiting - University of Chicago
Chicago, Illinois, United States
Recruiting - Mayo Clinic Rochester
Rochester, Minnesota, United States
Recruiting - Memorial Sloan Kettering Cancer Center
New York, New York, United States
Recruiting - Cleveland Clinic
Cleveland, Ohio, United States
Recruiting - Oregon Health and Science University
Portland, Oregon, United States
Recruiting - Next Oncology Houston
Houston, Texas, United States
Recruiting - the University of Texas Md Anderson Cancer Center
Houston, Texas, United States
Recruiting - Next Oncology Dallas
Irving, Texas, United States
Recruiting - Next Oncology Virginia
Fairfax, Virginia, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 26 Oct 2023
- Primary completion
- 31 Mar 2027
- Completion
- 31 Jul 2027
- Last update posted
- 9 Jul 2026
- Registered enrollment
- 140
- Registry id
- NCT05873686
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.